In its continued effort to please shareholders by narrowing its focus back to pharmaceuticals, Pfizer Inc. announced May 22 that it will shed its remaining 80% ownership of the animal health business that it spun out in February for $2.2 billion in returns.
While the move should not be a surprise to shareholders of either company, the timing was earlier than expected. Analysts had anticipated that Pfizer would wait at least 180 days before divesting the remaining portion of Zoetis Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?